2019
DOI: 10.1002/kjm2.12161
|View full text |Cite
|
Sign up to set email alerts
|

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Abstract: Colorectal cancer is a major public health problem worldwide, and locally advanced rectal cancer (LARC) is known for its poor prognosis. A multimodal treatment approach is the only method to achieve satisfactory local recurrence and survival rates in LARC. Determining which therapeutic modality for LARC has the most satisfactory influence on quality of life and disease outcome is still controversial. LARC treatment is subject to continuous advancement due to the development of new and better diagnostic tools, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 81 publications
(227 reference statements)
3
9
0
Order By: Relevance
“…Moreover, the number of harvested lymph nodes essentially decreased after preoperative CCRT (median, 4-14) (39). In the present study, the median number of harvested lymph nodes after neoadjuvant CCRT was 10 (range, [8][9][10][11][12][13][14], which is consistent with previous results (39).…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Moreover, the number of harvested lymph nodes essentially decreased after preoperative CCRT (median, 4-14) (39). In the present study, the median number of harvested lymph nodes after neoadjuvant CCRT was 10 (range, [8][9][10][11][12][13][14], which is consistent with previous results (39).…”
Section: Discussionsupporting
confidence: 92%
“…However, a comparable DRM distance and favorable negative rates of CRM were reached. The introduction of extended oxaliplatin-based chemotherapy and a longer interval between radiotherapy completion and robotic surgery might have contributed to the success (8,33). The sphincter preservation rate in patients with rectal cancer in our study was 96.3%, comparable to that reported by Kim et al (18) and Saklani et al (16).…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Microscopically, no differences were noted regarding the histologic grade, PNI, and CRM distance between the three groups. In addition, LVI and advanced stage were observed in the LS group, probably because of fewer patients receiving preoperative CCRT in the LS group because neoadjuvant therapy can decrease the size of tumor cells, besides downstaging or even causing complete remission after the treatment [24,25]. However, no differences were noted regarding TRS and CR among the three groups.…”
Section: Discussionmentioning
confidence: 89%
“…Microscopically, no differences were noted regarding the histologic grade, PNI, and CRM distance between the three groups. In addition, LVI and advanced stage were observed in the LS group, probably because of fewer patients receiving preoperative CCRT in the LS group because neoadjuvant therapy can 9 decrease the size of tumor cells, besides downstaging or even causing complete remission after the treatment [24,25]. However, no differences were noted regarding TRS and CR among the three groups.…”
Section: Discussionmentioning
confidence: 99%